Keyphrases
Human Pluripotent Stem Cells (hPSCs)
60%
Genetic Aberrations
40%
Cell Malignancy
40%
Teratoma Assay
40%
Humanized Mice
40%
Immunodeficient Mice
40%
Stem Cells
40%
Cell-based
40%
Epigenetics
40%
Pluripotent
40%
Safety Issues
40%
Tumor Risk
40%
Cell Population
40%
Tumor Formation
33%
Aberrations
26%
Malignant Transformation
23%
Regenerative Medicine
23%
Malignancy
20%
Safe Application
13%
Cause-effect
13%
Intrinsic Properties
13%
Property Effects
13%
Directed Differentiation
13%
Plethora
13%
Cellular Products
13%
Type 1 Diabetes Mellitus (T1DM)
13%
In Cancer
13%
Undifferentiated Cells
13%
Functional Impact
13%
Differentiation Protocol
13%
Human PSC
11%
Synteny
11%
Malignant Features
10%
Pathology Evaluation
10%
Stem Cell Lines
10%
In Vitro Techniques
10%
Humanized Immune System
10%
Malignancy-associated
10%
Mouse Model
10%
Transplantation
10%
Tumor Development
10%
Plasma Samples
10%
High Incidence
10%
Tumor Samples
10%
Expression Level
10%
Malignant Tumor
10%
After Injection
10%
MiRNA Expression
10%
Humanized Mouse Model
10%
Immunodeficient
10%
Medicine and Dentistry
Neoplasm
100%
Pluripotent Stem Cell
80%
Human Pluripotent Stem Cell
46%
Dentigerous Cyst
45%
Cancer
45%
Stem Cell Therapy
45%
Malignant Neoplasm
42%
Stem Cell
40%
Cell Population
40%
Germinoma
40%
Yolk Sac
40%
Carcinogenesis
33%
Medicine
23%
Malignant Transformation
23%
Disease
13%
Infancy
13%
Diabetes Mellitus
13%
Endodermal Sinus Tumor
11%
Stem Cell Line
10%
Immune System
10%
2102EP Cell Line
10%
microRNA
10%
In Vitro
10%
Embryonal Carcinoma
5%
Diseases
5%
Safety Assessment
5%
Clinical Trial
5%
Gene Expression
5%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
66%
Teratoma
60%
NOD SCID Gamma Mouse
40%
Yolk Sac Tumor
40%
Germ Cell Tumor
40%
Malignant Neoplasm
33%
Mouse Model
26%
Carcinogenesis
26%
Safety Assessment
20%
Embryonal Carcinoma
20%
Clinical Trial
20%
Diseases
20%
Malignant Transformation
13%
microRNA
13%
